A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1

Diabetes Care

Volumn 31, Issue 3, 2008, Pages 528-533

  Sosenko, Jay M ^a   Krischer, Jeffrey P ^b   Palmer, Jerry P ^c   Mahon, Jeffrey ^d   Cowie, Catherine ^e   Greenbaum, Carla J ^f   Cuthbertson, David ^b   Lachin, John M ^g   Skyler, Jay S ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f BENAROYA RESEARCH INSTITUTE   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCOSE; HUMULIN U; INSULIN; INSULIN ZINC SUSPENSION; PANCREAS ISLET CELL ANTIBODY; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; DIABETIC PATIENT; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PREVENTIVE MEDICINE; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; MIDDLE AGED; PANCREAS ISLET; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; AUTOANTIBODIES; BLOOD GLUCOSE; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 44349193971     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1459     Document Type: Article

References (23)

1. Gale EA, Bingley PJ, Emmett CL, Collier T, the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group: European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1. Lancet 363:925-931, 2004
2. Diabetes Prevention Trial-Type 1 Diabetes Study Group: Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691, 2002
3. Diabetes Prevention Trial-Type 1 Diabetes Study Group: Effects of oral insulin in relatives of patients with type 1 diabetes. Diabetes Care 28:1068-1076, 2005
4. Sosenko J, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS, the Diabetes Prevention Trial-Type 1 Study Group: Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes. Diabetes Care 30:38-42, 2007
5. Yu L, Cuthbertson DD, Eisenbarth GS, Krischer JP: Prevalence of GAD and ICA512 (IA-2) autoantibodies by relationship to proband. Ann N Y Acad Sci. 958:254-258, 2002
6. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
7. Haffner SM, Miettinen H, Stern MP: The homeostasis model in the San Antonio Heart Study. Diabetes Care 20:1087-1092, 1997
8. Sosenko J, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS: Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 29:643-649, 2006
9. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
10. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC: Insulin resistance is a risk factor for progression of type 1 diabetes. Diabetologia 47:1661-1667, 2004
11. Mrena S, Virtanen SM, Laippala P, Kulmala P, Hannila ML, Åkerblom HK, Knip M: Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 29:662-667, 2006
12. Bingley PJ, Gale EAM, the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group: Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 49:881-890, 2006
13. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, the Diabetes Prevention Trial-Type 1 Study Group: Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314-2320, 2007
14. Riley WJ, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, MaloneJ, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167-1172, 1990
15. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF: Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
16. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP: Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes. Diabetes 48:170-175, 1999
17. Truyen I, De Grijse J, Weets I, Kaufman L, Pipeleers L, Nanos N, Decochez K, Hilbrands R, Kaufman JM, Keymeulen B, Mathieu C, Van Gaal L, Pipleers DG, Gorus FK, the Belgian Diabetes Registry: Identification of prediabetes in first-degree relatives at intermediate risk of type 1 diabetes. Clin Exp Immunol 149:243-250, 2007
18. Barker JM, McFann K, Harrison LC, Fourlanos S, Krischer J, Cuthbertson D, Chase HP, Eisenbarth GS, the DPT-1 Study Group: Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Peadiatr 150:31-36, 2007
19. Rosenbloom AL, Hunt SS, Rosenbloom EK, Maclaren NK: Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes. Diabetes 31:385-387, 1982
20. Beer SF, Heaton DA, Alberti KGMM, Pyke A, Leslie RDG: Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins. Diabetologia 33:497-502, 1990
21. Kibirige M, Metcalf B, Renuka, Wilkin TJ: Testing the accelerator hypothesis. Diabetes Care 26:2865-2870, 2003
22. Betts P, Mulligan J, Ward P, Smith B, Wilkin T: Increasing body weight predicts the earlier onset of insulin-dependent diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med 22:144-151, 2005
23. Lachin JM: Biostatistical Methods: The Assessment of Relative Risks. New York, Wiley, 2000